ZHX2 and breast carcinoma: Given this, we generated a series of TNBC breast cancer cell lines where we depleted endogenous ZHX2 expression and restored with exogenous shRNA-resistant ZHX2 WT or mutant versions (D489A, R491A, E579A, R581A, K582, R674A, E678A, or R680A).